Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Star Combo Pharma Ltd. (AU:S66)
ASX:S66
Holding AU:S66?
Track your performance easily
S66 Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.09 - AU$0.25
Previous CloseAU$0.17
Volume20.00K
Average Volume (3M)27.27K
Market Cap
AU$22.95M
Enterprise ValueAU$16.68M
Total Cash (Recent Filing)AU$10.39M
Total Debt (Recent Filing)AU$4.12M
Price to Earnings (P/E)30.9
Beta0.47
Next Earnings
Feb 25, 2025EPS EstimateN/A
Next Dividend Ex-Date
Oct 14, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume27,271
Standard Deviation0.16
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Star Combo Pharma Ltd. News
PremiumCompany Announcements
Star Combo Pharma Expands into Gummy MarketS66 FAQ
What was Star Combo Pharma Ltd.’s price range in the past 12 months?
Star Combo Pharma Ltd. lowest share price was AU$0.09 and its highest was AU$0.25 in the past 12 months.
What is Star Combo Pharma Ltd.’s market cap?
Currently, no data Available
When is Star Combo Pharma Ltd.’s upcoming earnings report date?
Star Combo Pharma Ltd.’s upcoming earnings report date is Feb 25, 2025 which is in 158 days.
How were Star Combo Pharma Ltd.’s earnings last quarter?
Star Combo Pharma Ltd. released its earnings results on Aug 20, 2024. The company reported AU$0.005 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.005.
Is Star Combo Pharma Ltd. overvalued?
According to Wall Street analysts Star Combo Pharma Ltd.’s price is currently Overvalued.
Does Star Combo Pharma Ltd. pay dividends?
Star Combo Pharma Ltd. pays a Notavailable dividend of <AU$0.01 which represents an annual dividend yield of N/A. See more information on Star Combo Pharma Ltd. dividends here
What is Star Combo Pharma Ltd.’s EPS estimate?
Star Combo Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Star Combo Pharma Ltd. have?
Star Combo Pharma Ltd. has 135,002,980 shares outstanding.
What happened to Star Combo Pharma Ltd.’s price movement after its last earnings report?
Star Combo Pharma Ltd. reported an EPS of AU$0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Star Combo Pharma Ltd.?
Currently, no hedge funds are holding shares in AU:S66
---
Star Combo Pharma Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
86.81%
12-Months-Change
Fundamentals
Return on Equity
2.25%
Trailing 12-Months
Asset Growth
1.39%
Trailing 12-Months
Company Description
Star Combo Pharma Ltd.
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as face masks, moisturizing creams, serums, concentrates, and oils. Star Combo Pharma markets its products worldwide. It operates in two segments. Star Combo segment engages in the development, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment has made up of the Australia-China e-commerce platform that offers over 5,000 product lines directly to Chinese health product consumers; and Koala Mall's two retail stores in Sydney.
---
Technical Analysis
---